Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02760069 · ClinicalTrials.gov registry record · Phase 4
Isopropyl Alcohol vs Ondansetron for Nausea in the Emergency Department
A Phase 4 study of Nausea, sponsored by Brooke Army Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 122
- Enrollment target
- 1
- Study location
NCT02760069 is a Phase 4 study of Nausea that has completed, run by Brooke Army Medical Center. The registered enrollment target is 122 participants, below the 237-participant average among 17 other Nausea trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02760069, a Phase 4 study of Nausea, has completed, sponsored by Brooke Army Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 122 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will compare the efficacy of isopropyl alcohol and conventional anti-emetics with three study arms: (1) inhaled isopropyl alcohol plus oral ondansetron; (2) inhaled isopropyl alcohol plus oral placebo; (3) inhaled placebo plus oral ondansetron.
Conditions Studied
Interventions
- DRUG Inhaled isopropyl alcohol
- DRUG Oral ondansetron
- DRUG Inhaled normal saline
- DRUG Oral placebo
Study Locations (1)
Texas
- San Antonio Military Medical Center - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2016-01 |
| Est. Completion | 2017-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02760069
The ClinicalTrials.gov registry entry for NCT02760069 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 237-participant average among 17 other Nausea trials with a reported enrollment target (49% lower). The listed sponsor is Brooke Army Medical Center, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Nausea appearing as the primary indexed condition, and to 4 interventions - of which Inhaled isopropyl alcohol is the first listed.
NCT02760069 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT02760069 about?
NCT02760069 is a clinical study titled "Isopropyl Alcohol vs Ondansetron for Nausea in the Emergency Department". This study will compare the efficacy of isopropyl alcohol and conventional anti-emetics with three study arms: (1) inhaled isopropyl alcohol plus oral ondansetron; (2) inhaled isopropyl alcohol plus oral placebo; (3) inhaled placebo plus oral ondansetron.
What is the current status of trial NCT02760069?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 122 participants. The study started on 2016-01. Estimated completion is 2017-11.
What conditions does trial NCT02760069 study?
This clinical trial studies the following conditions: Nausea.
What interventions are being tested in trial NCT02760069?
The interventions under investigation include: Inhaled isopropyl alcohol (DRUG), Oral ondansetron (DRUG), Inhaled normal saline (DRUG), Oral placebo (DRUG).
Who is sponsoring clinical trial NCT02760069?
This trial is sponsored by Brooke Army Medical Center, which has 54 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02760069 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nausea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Aprepitant Versus Ondansetron in Preoperative Triple-therapy Treatment of Nausea and Vomiting
COMPLETED · Phase 4
-
The Montefiore Metoclopramide Study
COMPLETED · Phase 4
-
Inhaled Isopropyl Alcohol for Treatment of Nausea
RECRUITING · Phase 2
-
Alternate Nostril Breathing (ANB) for 1st Trimester Nausea and Vomiting
RECRUITING · NA
-
Antiemetic Fosaprepitant To Remedy Nausea and Vomiting
RECRUITING · Phase 2
-
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.